Evidence map›Paper›PMID 38639799›Full record

ArticleVirchows Archiv : an international journal of pathology2024

Correction to: Multicenter evaluation of an automated, multiplex, RNA-based molecular assay for detection of ALK, ROS1, RET fusions and MET exon 14 skipping in NSCLC.

Linea Melchior, Astrid Hirschmann, Paul Hofman, Christophe Bontoux, Angel Concha, Salima Mrabet-Dahbi, Pascal Vannuffel, Emmanuel Watkin, Martina Putzová, Stefania Scarpino and 4 more

Abstract readPublished Erratum
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Linea MelchiorDepartment of Pathology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark. linea.cecilie.melchior@regionh.dk.
Astrid HirschmannDepartment of Pathology, Luzerner Kantonsspital, Lucerne, Switzerland.
Paul HofmanLaboratory of Clinical and Experimental Pathology, Hôpital Pasteur, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, France.
Christophe BontouxLaboratory of Clinical and Experimental Pathology, Hôpital Pasteur, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, France.
Angel ConchaComplejo Hospitalario de A Coruña, Corunna, Spain.
Salima Mrabet-DahbiInstitut für Pathologie, Klinikum Kassel, Kassel, Germany.
Pascal VannuffelInstitut de Pathologie et de Génétique, Gosselies, Belgium.
Emmanuel WatkinCabinet de Pathologie Cypath, Lyon, France.
Martina PutzováBioptická Laboratoř, Pilsen, Czechia.
Stefania ScarpinoDepartment of Clinical and Molecular Medicine, Pathology Unit, St. Andrea University Hospital, University of Rome La Sapienza, Rome, Italy.
Anne CayreUF de Pathologie, Centre Jean Perrin, INSERM U1240, Clermont-Ferrand, France.
Paloma MartinMolecular Pathology Group, Department of Pathology, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA), Madrid, Spain.
Robert StoehrInstitute of Pathology, University Erlangen-Nürnberg, Erlangen, Germany.
Arndt HartmannInstitute of Pathology, University Erlangen-Nürnberg, Erlangen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38639799
PMCPMC11564354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.